Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis.

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-03-01 DOI:10.21873/invivo.13883
Özlem Polat, Gunseli Orhun, Ilkay Anakli, Vuslat Yilmaz, Gizem Koral, Canan Ulusoy, Mert Canbaz, Perihan Ergin Ozcan, Erdem Tüzün, Figen Esen
{"title":"Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis.","authors":"Özlem Polat, Gunseli Orhun, Ilkay Anakli, Vuslat Yilmaz, Gizem Koral, Canan Ulusoy, Mert Canbaz, Perihan Ergin Ozcan, Erdem Tüzün, Figen Esen","doi":"10.21873/invivo.13883","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Sepsis-induced acute kidney injury is a fatal, potentially reversible clinical condition. C5a receptor (C5aR) has been implied to play pivotal roles in both autophagy and sepsis-induced organ dysfunction. The aim of this study was to demonstrate the effects of intravenous immunoglobulin preparations on the expression of autophagy markers and investigate possible association between C5aR expression and autophagy in the kidney tissue of septic rats.</p><p><strong>Materials and methods: </strong>Sepsis was induced by cecal ligation perforation (CLP) in rats, which were divided into control, sham, CLP+saline, CLP+IgG (250 mg/kg, <i>iv</i>), and CLP+immunoglobulins enriched with immunoglobulin M (IgGAM) (250 mg/kg, <i>iv</i>) groups. Kidney samples were obtained in two sets of experiments to examine the early (1 day) and late (10 days) effects of treatment. Renal expression levels of C5aR, LC3A/B, and beclin-1 were measured using immunoblotting.</p><p><strong>Results: </strong>CLP did not enhance the renal expression of autophagy markers or C5aR. Contrariwise, IgG, and IgGAM administration reduced mortality caused by the CLP procedure and significantly increased C5aR, beclin-1, and LC3A/B expression levels in kidney samples of septic rats. Surviving rats had higher renal expression levels of C5aR, beclin-1, and LC3A/B than deceased rats. Expression levels of C5aR, beclin-1, and LC3A/B showed a strong correlation during the early stage of CLP-induced sepsis but not in the late stage.</p><p><strong>Conclusion: </strong>Human-derived immunoglobulin preparations may ameliorate sepsis-related organ dysfunction partially through autophagy-related mechanisms. In the early stage of treatment, enhancement of autophagy in the kidney appears to be associated with C5aR expression.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 2","pages":"810-818"},"PeriodicalIF":1.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884498/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.13883","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: Sepsis-induced acute kidney injury is a fatal, potentially reversible clinical condition. C5a receptor (C5aR) has been implied to play pivotal roles in both autophagy and sepsis-induced organ dysfunction. The aim of this study was to demonstrate the effects of intravenous immunoglobulin preparations on the expression of autophagy markers and investigate possible association between C5aR expression and autophagy in the kidney tissue of septic rats.

Materials and methods: Sepsis was induced by cecal ligation perforation (CLP) in rats, which were divided into control, sham, CLP+saline, CLP+IgG (250 mg/kg, iv), and CLP+immunoglobulins enriched with immunoglobulin M (IgGAM) (250 mg/kg, iv) groups. Kidney samples were obtained in two sets of experiments to examine the early (1 day) and late (10 days) effects of treatment. Renal expression levels of C5aR, LC3A/B, and beclin-1 were measured using immunoblotting.

Results: CLP did not enhance the renal expression of autophagy markers or C5aR. Contrariwise, IgG, and IgGAM administration reduced mortality caused by the CLP procedure and significantly increased C5aR, beclin-1, and LC3A/B expression levels in kidney samples of septic rats. Surviving rats had higher renal expression levels of C5aR, beclin-1, and LC3A/B than deceased rats. Expression levels of C5aR, beclin-1, and LC3A/B showed a strong correlation during the early stage of CLP-induced sepsis but not in the late stage.

Conclusion: Human-derived immunoglobulin preparations may ameliorate sepsis-related organ dysfunction partially through autophagy-related mechanisms. In the early stage of treatment, enhancement of autophagy in the kidney appears to be associated with C5aR expression.

免疫球蛋白治疗大鼠脓毒症模型中C5a受体及自噬相关Beclin-1和LC3A/B的表达水平同时增强
背景/目的:败血症引起的急性肾损伤是一种致命的、潜在可逆的临床疾病。C5a受体(C5aR)在自噬和脓毒症诱导的器官功能障碍中起关键作用。本研究旨在证明静脉注射免疫球蛋白制剂对脓毒症大鼠肾组织中自噬标志物表达的影响,并探讨C5aR表达与自噬之间的可能关联。材料与方法:将盲肠结扎穿孔(CLP)致脓毒症大鼠分为对照组、假手术组、CLP+生理盐水组、CLP+IgG组(250 mg/kg, iv)、CLP+含免疫球蛋白M (IgGAM)的免疫球蛋白组(250 mg/kg, iv)。在两组实验中获得肾脏样本,以检查治疗的早期(1天)和晚期(10天)效果。采用免疫印迹法检测C5aR、LC3A/B和beclin-1在肾脏中的表达水平。结果:CLP未增强肾细胞自噬标志物和C5aR的表达。相反,给药IgG和IgGAM降低了CLP手术引起的死亡率,并显著增加了脓毒症大鼠肾脏样本中C5aR、beclin-1和LC3A/B的表达水平。存活大鼠肾脏中C5aR、beclin-1和LC3A/B的表达水平高于死亡大鼠。C5aR、beclin-1、LC3A/B表达水平在clp致脓毒症早期有较强的相关性,而在晚期无相关性。结论:人源性免疫球蛋白制剂可能通过自噬相关机制部分改善败血症相关器官功能障碍。在治疗早期,肾脏自噬的增强似乎与C5aR表达有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信